203 related articles for article (PubMed ID: 36832081)
1. Molecular Imaging Diagnosis of Renal Cancer Using
Tataru OS; Marchioni M; Crocetto F; Barone B; Lucarelli G; Del Giudice F; Busetto GM; Veccia A; Lo Giudice A; Russo GI; Luzzago S; Piccinelli ML; Vartolomei MD; Musi G; Ferro M
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832081
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness Analysis of
Su ZT; Patel HD; Huang MM; Meyer AR; Pavlovich CP; Pierorazio PM; Javadi MS; Allaf ME; Rowe SP; Gorin MA
Eur Urol Focus; 2021 Jul; 7(4):827-834. PubMed ID: 32115400
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of
Parihar AS; Mhlanga J; Ronstrom C; Schmidt LR; Figenshau RS; Dehdashti F; Wahl RL
J Nucl Med; 2023 Jan; 64(1):90-95. PubMed ID: 35772963
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
Gorin MA; Rowe SP; Baras AS; Solnes LB; Ball MW; Pierorazio PM; Pavlovich CP; Epstein JI; Javadi MS; Allaf ME
Eur Urol; 2016 Mar; 69(3):413-6. PubMed ID: 26386607
[TBL] [Abstract][Full Text] [Related]
5. Protocol for a MULTI-centre feasibility study to assess the use of
Warren H; Wagner T; Gorin MA; Rowe S; Holman BF; Pencharz D; El-Sheikh S; Barod R; Patki P; Mumtaz F; Bex A; Kasivisvanathan V; Moore CM; Campain N; Cartledge J; Scarsbrook A; Hassan F; O'Brien TS; Stewart GD; Mendichovszky I; Dizdarevic S; Alanbuki A; Wildgoose WH; Wah T; Vindrola-Padros C; Pizzo E; Dehbi HM; Lorgelly P; Gurusamy K; Emberton M; Tran MGB
BMJ Open; 2023 Jan; 13(1):e067496. PubMed ID: 36693694
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on
Papathomas T; Tzortzakakis A; Sun N; Erlmeier F; Feuchtinger A; Trpkov K; Bazarova A; Arvanitis A; Wang W; Bozoky B; Kokaraki G; Axelsson R; Walch A
Eur Urol Open Sci; 2020 Dec; 22():88-96. PubMed ID: 34337482
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99 m-sestamibi single-photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses.
Viswambaram P; Swarbrick N; Picardo A; Hohnen A; Pham K; Macdonald W; Hayne D; Hamid A
BJU Int; 2022 Nov; 130 Suppl 3():23-31. PubMed ID: 35365966
[TBL] [Abstract][Full Text] [Related]
9.
Tzortzakakis A; Papathomas T; Gustafsson O; Gabrielson S; Trpkov K; Ekström-Ehn L; Arvanitis A; Holstensson M; Karlsson M; Kokaraki G; Axelsson R
Scand J Urol; 2022; 56(5-6):375-382. PubMed ID: 36065481
[TBL] [Abstract][Full Text] [Related]
10. Use of quantitative SPECT/CT reconstruction in
Jones KM; Solnes LB; Rowe SP; Gorin MA; Sheikhbahaei S; Fung G; Frey EC; Allaf ME; Du Y; Javadi MS
Ann Nucl Med; 2018 Feb; 32(2):87-93. PubMed ID: 29214562
[TBL] [Abstract][Full Text] [Related]
11. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
Schalin-Jäntti C; Ryhänen E; Heiskanen I; Seppänen M; Arola J; Schildt J; Väisänen M; Nelimarkka L; Lisinen I; Aalto V; Nuutila P; Välimäki MJ
J Nucl Med; 2013 May; 54(5):739-47. PubMed ID: 23554505
[TBL] [Abstract][Full Text] [Related]
12. Positron Emission Tomography/Computed Tomography with
Hekman MCH; Rijpkema M; Aarntzen EH; Mulder SF; Langenhuijsen JF; Oosterwijk E; Boerman OC; Oyen WJG; Mulders PFA
Eur Urol; 2018 Sep; 74(3):257-260. PubMed ID: 29730017
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning Integrating
Klontzas ME; Koltsakis E; Kalarakis G; Trpkov K; Papathomas T; Karantanas AH; Tzortzakakis A
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509214
[TBL] [Abstract][Full Text] [Related]
14. Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review.
Roussel E; Capitanio U; Kutikov A; Oosterwijk E; Pedrosa I; Rowe SP; Gorin MA
Eur Urol; 2022 May; 81(5):476-488. PubMed ID: 35216855
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of 99mTc-sestamibi SPECT/CT for detecting renal oncocytomas and other benign renal lesions: a systematic review and meta-analysis.
Wilson MP; Katlariwala P; Murad MH; Abele J; McInnes MDF; Low G
Abdom Radiol (NY); 2020 Aug; 45(8):2532-2541. PubMed ID: 32193593
[TBL] [Abstract][Full Text] [Related]
16. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
Chen YH; Chen HT; Lee MC; Liu SH; Wang LY; Lue KH; Chan SC
Ann Nucl Med; 2020 Aug; 34(8):527-537. PubMed ID: 32436180
[TBL] [Abstract][Full Text] [Related]
17. Characterizing Indeterminate Renal Masses with Molecular Imaging: the Role of
Reynolds AM; Porter KK
Curr Urol Rep; 2017 Sep; 18(11):86. PubMed ID: 28900880
[TBL] [Abstract][Full Text] [Related]
18. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
[TBL] [Abstract][Full Text] [Related]
19. Correlation of
Rowe SP; Gorin MA; Solnes LB; Ball MW; Choudhary A; Pierorazio PM; Epstein JI; Javadi MS; Allaf ME; Baras AS
EJNMMI Res; 2017 Oct; 7(1):80. PubMed ID: 28971329
[TBL] [Abstract][Full Text] [Related]
20. Use of
Wu D; Ylli D; Gomes Lima CJ; Lee W; Burman KD; Wartofsky L; Van Nostrand D
Endocrine; 2018 Oct; 62(1):57-63. PubMed ID: 29797211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]